Literature DB >> 9877017

The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.

D H Malin1, J R Lake, M Shenoi, T P Upchurch, S C Johnson, W E Schweinle, C D Cadle.   

Abstract

Nitric oxide synthesis contributes to opiate tolerance and dependence. Nicotine dependence and abstinence syndrome in the rat appear to involve opiate mechanisms. Therefore, it was postulated that nitric oxide synthase (NOS) activity might be essential for the expression of nicotine abstinence syndrome. Twenty-one rats were rendered dependent by SC infusion of 9 mg/kg per day nicotine tartrate via Alzet osmotic minipump. Rats were pretreated SC with vehicle alone, or with 18 or 30 mg/kg of the NOS inhibitor L-NNA (nitro-L-arginine). Thirty minutes later, rats were challenged by 1 mg/kg of the nicotinic antagonist mecamylamine SC and observed for 30 additional minutes. Rats pretreated with vehicle displayed a total of 68.7+/-8.0 mecamylamine-precipitated abstinence signs (mean+/-SEM), while those receiving 18 or 30 mg/kg L-NNA had 12.7+/-2.0 and 5.1+/-1.7 signs, respectively. All three groups differed significantly from one another according to Dunn's post-hoc procedure. Rats pretreated with L-NNA combined with an excess of the NOS substrate L-arginine had significantly more mecamylamine-precipitated abstinence signs than rats receiving L-NNA combined with D-arginine. Also, D-NNA, which does not selectively bind to NOS, was significantly less effective than L-NNA in preventing mecamylamine-precipitated abstinence syndrome. Additional studies determined the effect of L-NNA on spontaneous nicotine abstinence syndrome. Rats were assessed for abstinence signs at 17 and 20 h after termination of nicotine infusion. They received injections of 9, 18, or 30 mg/kg L-NNA SC or vehicle alone immediately before the 20-h observation; all rats were observed for 30 min. Signs at 20 h (post-injection) as a percentage of signs at 17 h (pre-injection) declined significantly as a function of L-NNA dose. Once again, this effect was attenuated significantly more by co-administration of L-arginine than by D-arginine. The overall pattern of results suggests that nitric oxide synthesis is critical to the expression of nicotine abstinence syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877017     DOI: 10.1007/s002130050778

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

2.  Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.

Authors:  Vincenzo Di Matteo; Massimo Pierucci; Arcangelo Benigno; Ennio Esposito; Giuseppe Crescimanno; Giuseppe Di Giovanni
Journal:  CNS Neurosci Ther       Date:  2010-03-25       Impact factor: 5.243

3.  Investigation of extracellular L-citrulline concentration in the striatum during alcohol withdrawal in rats.

Authors:  M Z Gören; F Aricioglu-Kartal; T Yurdun; I T Uzbay
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

4.  Bupropion attenuates nicotine abstinence syndrome in the rat.

Authors:  David H Malin; J Ronald Lake; Tanya D Smith; Habil N Khambati; Rhonda L Meyers-Paal; Ana L Montellano; Ryan E Jennings; Daniel S Erwin; Stacey E Presley; Barbara A Perales
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

5.  Evidence for the role of nitric oxide in nicotine-induced locomotor sensitization in mice.

Authors:  Umut Ulusu; I Tayfun Uzbay; Hakan Kayir; Tevfik Alici; Sirel Karakas
Journal:  Psychopharmacology (Berl)       Date:  2004-10-09       Impact factor: 4.530

6.  Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells.

Authors:  Chang Hee Jung; Woo Je Lee; Jenie Yoonoo Hwang; Min Jung Lee; So Mi Seol; Yun Mi Kim; Yoo La Lee; Hyun Sik Kim; Min-Seon Kim; Joong-Yeol Park
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

7.  Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells.

Authors:  Chang Hee Jung; Min Jung Lee; Yu Mi Kang; Yoo La Lee; Hae Kyeong Yoon; Sang-Wook Kang; Woo Je Lee; Joong-Yeol Park
Journal:  Cardiovasc Diabetol       Date:  2014-02-12       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.